SEC Filings for Core Laboratories N.V. (CLB)

$ 21.8967   1.7067 (+8.45%) Volume: 72.94k 11:10 AM EST 23-Nov-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)4310/22/2020
8-KCurrent report pursuant to Section 13 or 15(d)1810/21/2020
8-KCurrent report pursuant to Section 13 or 15(d)15810/16/2020
8-KCurrent report pursuant to Section 13 or 15(d)510/15/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans1608/19/2020
S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuers3908/13/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)4207/24/2020
8-KCurrent report pursuant to Section 13 or 15(d)1807/22/2020
8-KCurrent report pursuant to Section 13 or 15(d)507/17/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals107/08/2020
4Statement of changes in beneficial ownership of securities107/02/2020
11-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2106/26/2020
4Statement of changes in beneficial ownership of securities106/23/2020
8-KCurrent report pursuant to Section 13 or 15(d)3306/23/2020
SDSpecialized Disclosure Report305/21/2020
<<
First
<
Prev
123456789101112131415